Bronkaid LS-SYP
COMPOSITION : Ambroxol 30 mg + Guaiphenesin 50 mg + Levosalbutamol 1 mg
Description
Product Description
BRONKAID-LS Syrup is a combination respiratory formulation containing Ambroxol Hydrochloride, Guaiphenesin and Levosalbutamol. The combination brings together mucolytic, expectorant and bronchodilator actions and is formulated as an oral syrup.
It is supplied in a 100 mL bottle.
Therapeutic Information
Therapeutic Category
Respiratory / Cough & Expectorant
Drug Classes
| Ingredient | Pharmacological role |
|---|---|
| Ambroxol Hydrochloride | Mucolytic |
| Guaiphenesin | Expectorant |
| Levosalbutamol | β₂-adrenergic bronchodilator |
General therapeutic role
- Ambroxol helps reduce the viscosity of respiratory mucus.
- Guaiphenesin promotes the clearance of respiratory secretions.
- Levosalbutamol produces bronchodilation by stimulating β₂-adrenergic receptors.
This makes the combination relevant to productive cough associated with bronchospasm/airway obstruction, when clinically appropriate.
Additional information
| Composition |
Ambroxol Hydrochloride 30 mg + Guaiphenesin 50 mg + Levosalbutamol 1 mg |
|---|---|
| Dosage Form |
Syrup |
| Pack size |
100 mL |
| Therapeutic Segment |
Respiratory |
| Route |
Oral |
| Therapeutic Category |
Cough & Expectorant |
| MRP |
₹120/- |
| Origin |
India |
Related products
CLAV 625 LB
Composition: Amoxicillin Trihydrate eq. to amoxicillin (anhydrous) 500 mg + Potassium clavulanate diluted eq. to...
